Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes.
Marja‐Riitta Taskinen(Hospital District of Helsinki and Uusimaa), Hannele Yki‐Järvinen(University of Helsinki), Eero Helve(University of Helsinki), Esko A. Nikkilä(Cegep de Sept Iles), T Kuusi(University of Helsinki)
Arteriosclerosis An Official Journal of the American Heart Association Inc
March 1, 1988
Cited by 187
Related Papers
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
|New England Journal of Medicine|1987|3.9k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k